Please sign up for our mailing list if you are interested in receiving periodic announcements regarding clinical studies and other development activities we are conducting.
There may be opportunities to help Cognito in its development by participating in surveys, interviews, and other product research activities. These activities will help us develop products that best meet the needs of our patients and their care partners.
We are focused on developing device-based therapies to treat neurodegenerative diseases including Alzheimer's Disease. Before these therapies can be made available to those who may need them, they must go through clinical trials and receive approval from regulatory agencies such as the United States Food and Drug Administration (FDA). Obtaining approvals is the fastest way by which Cognito can provide new therapies to the largest number of patients around the world.